As 2021 draws to a close, I would like to thank our clients, partners, and employees for working with us towards creating better lives for patients around the world. Every day, we strive to deliver a superior service to the Life Sciences community.
For PM Holding, 2021 was a year of growth, change and transition. In June, a data-driven Contract Research Organization CROS NT, a PM Holding company, joined the leading international healthcare, and life sciences advisory services firm Alira Health. As PM Holding investing in Alira Health as a minority shareholder, we are excited to contribute to the mission of healthcare transformation, creating value for patients. This acquisition is another milestone on our road towards creating a partnership network that allows our customers to get increased value through integrated solutions and extensive service offerings, giving them access to endless opportunities.
When I look at 2022, the future is bright to satisfy the growing demand for technology in Life Sciences, we will focus on organic and inorganic growth. Our ambition is to play a leading role as technology experts and system integrators through Arithmos company, and as experts for Pharmacovigilance, Quality Assurance, Regulatory Compliance Solutions and Computer System Validation services through seQure company pan-European. In 2022, we will be expanding our geography, our team, and our portfolio.
At the beginning of the year, we said #nogoingback and we stand by this.
In 2022, we will embark on a new chapter that will accelerate our ability to achieve our mission of helping pharmaceutical, biotechnology, medical device industries, and academic area to carry out their work, regardless of what challenges we face.
I am excited to see what the new year will bring, and I am looking forward to working alongside my colleagues and our existing clients and new clients with the same commitment and diligence towards transforming the Life Sciences industry.
CEO of PM Holding (Arithmos, seQure)